A Phase II Study (NPC001) of Neoadjuvant Taxol and Carboplatin Followed by Concurrent Cisplatin-radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) with EBVDNA Monitoring
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListCHAN A.T., TEO P., MA B., ZEE B., KWAN W., HUI E.P., MOK T., KAM M., LEUNG S., CHAN L.S., CHIU K., CHAN K.W., LAI K., LAI M., MO F., YEO W., LEUNG W., CHOI P., LO Y., JOHNSON P.
Name of ConferenceProceedings of the American Society of Clinical Oncology, Thirty-Eighth Annual Meeting (May 18-21, 2002 Orlando, FL)
Country/Region of ConferenceUnited States of America
Proceedings TitleProceedings of the American Society of Clinical Oncology, Thirty-Eighth Annual Meeting (May 18-21, 2002 Orlando, FL)
Year2002
Month5
Issue Number21
PublisherASCO Program Committee
Place of PublicationUnited States of America, Orlando
Pages233
LanguagesEnglish-United Kingdom
KeywordsCISPLATIN-RADIOTHERAPY ; EBVDNA ; TAXOL

Last updated on 2018-18-01 at 22:51